110 related articles for article (PubMed ID: 11755355)
1. Biphenyls as potent vitronectin receptor antagonists.
Urbahns K; Härter M; Albers M; Schmidt D; Stelte-Ludwig B; Brüggemeier U; Vaupel A; Gerdes C
Bioorg Med Chem Lett; 2002 Jan; 12(2):205-8. PubMed ID: 11755355
[TBL] [Abstract][Full Text] [Related]
2. Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric acid amides.
Urbahns K; Härter M; Albers M; Schmidt D; Stelte-Ludwig B; Brüggemeier U; Vaupel A; Keldenich J; Lustig K; Tsujishita H; Gerdes C
Bioorg Med Chem Lett; 2007 Nov; 17(22):6151-4. PubMed ID: 17910915
[TBL] [Abstract][Full Text] [Related]
3. Biphenyls as potent vitronectin receptor antagonists. Part 2: biphenylalanine ureas.
Urbahns K; Härter M; Vaupel A; Albers M; Schmidt D; Brüggemeier U; Stelte-Ludwig B; Gerdes C; Tsujishita H
Bioorg Med Chem Lett; 2003 Mar; 13(6):1071-4. PubMed ID: 12643914
[TBL] [Abstract][Full Text] [Related]
4. Construction of a family of biphenyl combinatorial libraries: structure-activity studies utilizing libraries of mixtures.
Neustadt BR; Smith EM; Lindo N; Nechuta T; Bronnenkant A; Wu A; Armstrong L; Kumar C
Bioorg Med Chem Lett; 1998 Sep; 8(17):2395-8. PubMed ID: 9873548
[TBL] [Abstract][Full Text] [Related]
5. Disubstituted indazoles as potent antagonists of the integrin alpha(v)beta(3).
Batt DG; Petraitis JJ; Houghton GC; Modi DP; Cain GA; Corjay MH; Mousa SA; Bouchard PJ; Forsythe MS; Harlow PP; Barbera FA; Spitz SM; Wexler RR; Jadhav PK
J Med Chem; 2000 Jan; 43(1):41-58. PubMed ID: 10633037
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of highly potent and selective hetaryl ureas as integrin alpha(V)beta3-receptor antagonists.
Lange UE; Backfisch G; Delzer J; Geneste H; Graef C; Hornberger W; Kling A; Lauterbach A; Subkowski T; Zechel C
Bioorg Med Chem Lett; 2002 May; 12(10):1379-82. PubMed ID: 11992781
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta(3)-adrenergic receptor agonists: Part IV.
Nakajima Y; Imanishi M; Itou S; Hamashima H; Tomishima Y; Washizuka K; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Hattori K
Bioorg Med Chem Lett; 2008 Sep; 18(18):5037-40. PubMed ID: 18752946
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and SAR of N-substituted dibenzazepinone derivatives as novel potent and selective alpha(V)beta(3) antagonists.
Kling A; Backfisch G; Delzer J; Geneste H; Graef C; Holzenkamp U; Hornberger W; Lange UE; Lauterbach A; Mack H; Seitz W; Subkowski T
Bioorg Med Chem Lett; 2002 Feb; 12(3):441-6. PubMed ID: 11814816
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and initial evaluation of novel, non-peptidic antagonists of the alpha(v)-integrins alpha(v)beta(3) and alpha(v)beta(5).
Letourneau JJ; Liu J; Ohlmeyer MH; Riviello C; Rong Y; Li H; Appell KC; Bansal S; Jacob B; Wong A; Webb ML
Bioorg Med Chem Lett; 2009 Jan; 19(2):352-5. PubMed ID: 19081719
[TBL] [Abstract][Full Text] [Related]
10. Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis model.
Keenan RM; Lago MA; Miller WH; Ali FE; Cousins RD; Hall LB; Hwang SM; Jakas DR; Kwon C; Louden C; Nguyen TT; Ohlstein EH; Rieman DJ; Ross ST; Samanen JM; Smith BR; Stadel J; Takata DT; Vickery L; Yuan CC; Yue TL
Bioorg Med Chem Lett; 1998 Nov; 8(22):3171-6. PubMed ID: 9873697
[TBL] [Abstract][Full Text] [Related]
11. Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit.
Bishop GG; McPherson JA; Sanders JM; Hesselbacher SE; Feldman MJ; McNamara CA; Gimple LW; Powers ER; Mousa SA; Sarembock IJ
Circulation; 2001 Apr; 103(14):1906-11. PubMed ID: 11294811
[TBL] [Abstract][Full Text] [Related]
12. Isoxazolines as potent antagonists of the integrin alpha(v)beta(3).
Pitts WJ; Wityak J; Smallheer JM; Tobin AE; Jetter JW; Buynitsky JS; Harlow PP; Solomon KA; Corjay MH; Mousa SA; Wexler RR; Jadhav PK
J Med Chem; 2000 Jan; 43(1):27-40. PubMed ID: 10633036
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and preliminary biological evaluation of a focused combinatorial library of stereodiverse carbohydrate-scaffold-based peptidomimetics.
Moitessier N; Dufour S; Chrétien F; Thiery JP; Maigret B; Chapleur Y
Bioorg Med Chem; 2001 Feb; 9(2):511-23. PubMed ID: 11249143
[TBL] [Abstract][Full Text] [Related]
14. Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonists.
Keenan RM; Miller WH; Lago MA; Ali FE; Bondinell WE; Callahan JF; Calvo RR; Cousins RD; Hwang SM; Jakas DR; Ku TW; Kwon C; Nguyen TT; Reader VA; Rieman DJ; Ross ST; Takata DT; Uzinskas IN; Yuan CC; Smith BR
Bioorg Med Chem Lett; 1998 Nov; 8(22):3165-70. PubMed ID: 9873696
[TBL] [Abstract][Full Text] [Related]
15. Parallel solid-phase synthesis of vitronectin receptor (alphavbeta3) inhibitors.
Gopalsamy A; Yang H; Ellingboe JW; Kees KL; Yoon J; Murrills R
Bioorg Med Chem Lett; 2000 Aug; 10(15):1715-8. PubMed ID: 10937731
[TBL] [Abstract][Full Text] [Related]
16. Novel potent and selective alphavbeta3/alphavbeta5 integrin dual antagonists with reduced binding affinity for human serum albumin.
Raboisson P; Manthey CL; Chaikin M; Lattanze J; Crysler C; Leonard K; Pan W; Tomczuk BE; Marugán JJ
Eur J Med Chem; 2006 Jul; 41(7):847-61. PubMed ID: 16697080
[TBL] [Abstract][Full Text] [Related]
17. Biphenyl derivatives as novel dual NK(1)/NK(2)-receptor antagonists.
Mah R; Gerspacher M; von Sprecher A; Stutz S; Tschinke V; Anderson GP; Bertrand C; Subramanian N; Ball HA
Bioorg Med Chem Lett; 2002 Aug; 12(16):2065-8. PubMed ID: 12127505
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
Morini G; Comini M; Rivara M; Rivara S; Bordi F; Plazzi PV; Flammini L; Saccani F; Bertoni S; Ballabeni V; Barocelli E; Mor M
Bioorg Med Chem; 2008 Dec; 16(23):9911-24. PubMed ID: 18976927
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel short chain 4-substituted indoles as potent alphavbeta3 antagonist using structure-based drug design.
Raboisson P; Desjarlais RL; Reed R; Lattanze J; Chaikin M; Manthey CL; Tomczuk BE; Marugán JJ
Eur J Med Chem; 2007 Mar; 42(3):334-43. PubMed ID: 17184884
[TBL] [Abstract][Full Text] [Related]
20. Metalloproteinase inhibitor attenuates neointima formation and constrictive remodeling after angioplasty in rats: augmentative effect of alpha(v)beta(3) receptor blockade.
Margolin L; Fishbein I; Banai S; Golomb G; Reich R; Perez LS; Gertz SD
Atherosclerosis; 2002 Aug; 163(2):269-77. PubMed ID: 12052473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
